.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Baxter
UBS
Medtronic
Colorcon
Accenture
US Army
QuintilesIMS
Boehringer Ingelheim

Generated: November 21, 2017

DrugPatentWatch Database Preview

Ulipristal acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ulipristal acetate and what is the scope of ulipristal acetate freedom to operate?

Ulipristal acetate
is the generic ingredient in two branded drugs marketed by Teva Pharms Usa and Lab Hra Pharma, and is included in two NDAs. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Ulipristal acetate has sixty-three patent family members in twenty-six countries.

There are four drug master file entries for ulipristal acetate. One supplier is listed for this compound.

Summary for ulipristal acetate

Pharmacology for ulipristal acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
LOGILIA
ulipristal acetate
TABLET;ORAL207952-001Feb 13, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: ulipristal acetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,616,073Method for on-demand contraception► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ulipristal acetate

Country Document Number Estimated Expiration
Lithuania2419108► Subscribe
Cyprus1118236► Subscribe
China105267168► Subscribe
Russian Federation2011146058► Subscribe
Portugal2365800► Subscribe
Slovenia2419108► Subscribe
Slovenia2365800► Subscribe
Australia2010237120► Subscribe
World Intellectual Property Organization (WIPO)2011069871► Subscribe
China102245173► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Citi
Chubb
Fish and Richardson
Cantor Fitzgerald
Cerilliant
UBS
Johnson and Johnson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot